CUPRINA HOLDINGS CAYMAN-A (CUPR) Fundamental Analysis & Valuation

NASDAQ:CUPR • KYG2592E1026

Current stock price

0.36 USD
+0.04 (+11.08%)
At close:
0.35 USD
-0.01 (-2.78%)
After Hours:

This CUPR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. CUPR Profitability Analysis

1.1 Basic Checks

  • CUPR had negative earnings in the past year.
  • In the past year CUPR has reported a negative cash flow from operations.
CUPR Yearly Net Income VS EBIT VS OCF VS FCFCUPR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 -500K -1M -1.5M

1.2 Ratios

  • With a Return On Assets value of -32.67%, CUPR is not doing good in the industry: 60.85% of the companies in the same industry are doing better.
  • The Return On Equity of CUPR (-46.07%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -32.67%
ROE -46.07%
ROIC N/A
ROA(3y)-78.75%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CUPR Yearly ROA, ROE, ROICCUPR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 50 -50

1.3 Margins

  • CUPR does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CUPR Yearly Profit, Operating, Gross MarginsCUPR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 -1K -2K -3K

4

2. CUPR Health Analysis

2.1 Basic Checks

  • CUPR does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • CUPR has about the same amout of shares outstanding than it did 1 year ago.
  • CUPR has a worse debt/assets ratio than last year.
CUPR Yearly Shares OutstandingCUPR Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 5M 10M 15M 20M
CUPR Yearly Total Debt VS Total AssetsCUPR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 500K 1M 1.5M

2.2 Solvency

  • Based on the Altman-Z score of 0.61, we must say that CUPR is in the distress zone and has some risk of bankruptcy.
  • CUPR has a Altman-Z score (0.61) which is in line with its industry peers.
  • A Debt/Equity ratio of 0.02 indicates that CUPR is not too dependend on debt financing.
  • With a decent Debt to Equity ratio value of 0.02, CUPR is doing good in the industry, outperforming 70.37% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Altman-Z 0.61
ROIC/WACCN/A
WACC10.49%
CUPR Yearly LT Debt VS Equity VS FCFCUPR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 -1M -2M -3M -4M

2.3 Liquidity

  • A Current Ratio of 3.58 indicates that CUPR has no problem at all paying its short term obligations.
  • CUPR has a Current ratio of 3.58. This is in the better half of the industry: CUPR outperforms 60.32% of its industry peers.
  • A Quick Ratio of 3.58 indicates that CUPR has no problem at all paying its short term obligations.
  • CUPR has a Quick ratio of 3.58. This is in the better half of the industry: CUPR outperforms 69.31% of its industry peers.
Industry RankSector Rank
Current Ratio 3.58
Quick Ratio 3.58
CUPR Yearly Current Assets VS Current LiabilitesCUPR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2M 4M 6M

0

3. CUPR Growth Analysis

3.1 Past

  • CUPR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -68.35%.
  • The Revenue for CUPR has decreased by -52.08% in the past year. This is quite bad
  • CUPR shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -6.19% yearly.
EPS 1Y (TTM)-68.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-212.96%
Revenue 1Y (TTM)-52.08%
Revenue growth 3Y-6.19%
Revenue growth 5YN/A
Sales Q2Q%-43.9%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CUPR Yearly Revenue VS EstimatesCUPR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 20K 40K 60K 80K 100K

0

4. CUPR Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for CUPR. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CUPR Price Earnings VS Forward Price EarningsCUPR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CUPR Per share dataCUPR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1 0.2 -0.2 -0.3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. CUPR Dividend Analysis

5.1 Amount

  • No dividends for CUPR!.
Industry RankSector Rank
Dividend Yield 0%

CUPR Fundamentals: All Metrics, Ratios and Statistics

CUPRINA HOLDINGS CAYMAN-A

NASDAQ:CUPR (3/26/2026, 5:45:35 PM)

After market: 0.35 -0.01 (-2.78%)

0.36

+0.04 (+11.08%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)12-09
Earnings (Next)05-12
Inst Owners0.66%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap7.72M
Revenue(TTM)71.30K
Net Income(TTM)-3.54M
AnalystsN/A
Price TargetN/A
Short Float %0.07%
Short Ratio0.02
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 138.55
P/FCF N/A
P/OCF N/A
P/B 1.29
P/tB 1.29
EV/EBITDA N/A
EPS(TTM)-0.15
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.31
FCFYN/A
OCF(TTM)-0.31
OCFYN/A
SpS0
BVpS0.28
TBVpS0.28
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -32.67%
ROE -46.07%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-78.75%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 63.59%
Cap/Sales 33.8%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.58
Quick Ratio 3.58
Altman-Z 0.61
F-Score2
WACC10.49%
ROIC/WACCN/A
Cap/Depr(3y)100.2%
Cap/Depr(5y)N/A
Cap/Sales(3y)47.02%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-68.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-212.96%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-52.08%
Revenue growth 3Y-6.19%
Revenue growth 5YN/A
Sales Q2Q%-43.9%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-54.01%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y21.91%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y19.89%
OCF growth 3YN/A
OCF growth 5YN/A

CUPRINA HOLDINGS CAYMAN-A / CUPR Fundamental Analysis FAQ

What is the ChartMill fundamental rating of CUPRINA HOLDINGS CAYMAN-A (CUPR) stock?

ChartMill assigns a fundamental rating of 1 / 10 to CUPR.


Can you provide the valuation status for CUPRINA HOLDINGS CAYMAN-A?

ChartMill assigns a valuation rating of 0 / 10 to CUPRINA HOLDINGS CAYMAN-A (CUPR). This can be considered as Overvalued.


Can you provide the profitability details for CUPRINA HOLDINGS CAYMAN-A?

CUPRINA HOLDINGS CAYMAN-A (CUPR) has a profitability rating of 0 / 10.